Local view for "http://purl.org/linkedpolitics/eu/plenary/2007-04-25-Speech-3-335"
Predicate | Value (sorted: default) |
---|---|
rdf:type | |
dcterms:Date | |
dcterms:Is Part Of | |
dcterms:Language | |
lpv:document identification number |
"en.20070425.38.3-335"2
|
lpv:hasSubsequent | |
lpv:speaker | |
lpv:spoken text |
"Question No 4 by Glenis Willmott ()
Type 1 diabetes, a condition most commonly found in children, is a disease which predominantly affects European populations, more so than the much talked about type 2 diabetes. Finland has the highest registered number of sufferers in the world, with the UK ranked fourth on the list. There is little understanding of what causes type 1 diabetes and attention needs to be turned towards ensuring that sufferers can enjoy the best quality of life possible. A timely and accurate diagnosis and effective control is essential for this.
What measures does the Council intend to take to ensure not only that all diabetes sufferers have access to a minimum standard of care across Member States but also to ensure that the insulin pump, widely believed to be the best tool currently available to help well-motivated diabetes sufferers to achieve improved control and quality of life, is available to all those who need it?"@en1
|
lpv:spokenAs | |
lpv:unclassifiedMetadata |
"Subject: Type 1 diabetes"1
|
Named graphs describing this resource:
The resource appears as object in 2 triples